Hillman Cancer Ctr., University of Pittsburgh — Pittsburgh, Pennsylvania

Hillman Cancer Ctr., University of Pittsburgh is a clinical research site located in Pittsburgh, Pennsylvania, United States 15213.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Hillman Cancer Ctr., University of Pittsburgh has participated in 1 clinical trials.

Therapeutic areas: Cutaneous T-cell Lymphoma (CTCL),.

Sponsors: BioCryst Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Hillman Cancer Ctr., University of Pittsburgh?

Hillman Cancer Ctr., University of Pittsburgh has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Hillman Cancer Ctr., University of Pittsburgh conducted?

Hillman Cancer Ctr., University of Pittsburgh has 1 clinical trials on record. Their work covers Cutaneous T-cell Lymphoma (CTCL),.

Is Hillman Cancer Ctr., University of Pittsburgh accredited by Crixeo Health?

Hillman Cancer Ctr., University of Pittsburgh has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Hillman Cancer Ctr., University of Pittsburgh?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.